A Region on the Rise
The medical cannabis market in Latin America is experiencing rapid growth, driven by regulatory acceptance, rising patient populations, and the region's favorable cultivation conditions.
Country Highlights
Brazil: The Largest Domestic Market
Brazil has seen explosive growth, surpassing 873,000 registered medical cannabis patients by late 2025. The market benefits from improved access pathways and an increasing number of available cannabis-based products.
Colombia: The Export Powerhouse
Colombia leverages its favorable climate, low labor costs, and progressive regulations to attract foreign investment. The country is positioning itself as a major exporter, particularly to European markets requiring EU-GMP certified products.
Other Key Markets
Mexico, Argentina, Chile, and Peru continue developing their medical cannabis infrastructures. Most are focused on expanding prescription access and formalizing production frameworks.
Growth Drivers
- Regulatory reform: Governments view medical cannabis as a politically safer alternative to broader legalization.
- Clinical demand: Rising rates of chronic diseases and an aging population fuel demand for cannabis-based therapies.
- Production advantages: Low costs, ideal climates, and emerging EU-GMP expertise make the region attractive for both domestic supply and export.
Challenges Ahead
Despite the positive outlook, the market faces inconsistent regulations across countries, knowledge gaps among healthcare providers, and challenges with healthcare reimbursement policies that often require patients to bear full treatment costs.